SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than a buck.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RWReeves who wrote ()12/15/1999 5:01:00 PM
From: James Perry   of 743
 
Hey, I am not trying to throw a curveball at the board, BUT I was attracted to a biotech called Imatron (IMAT), a $3 stock with 80 million shares outstanding, which received FDA approval for diagnosis of coronary artery disease with a CT scan. But the huge market cap (3x80mil)turned me off. Still, the heart photos they could make from a CT scan were stunning. Then I saw that Accuimage (AIDP)was a software company, was less than a buck, only 10 million shares, and that at Accuimage.com they displayed photos of many body parts which were equally stunning. IMAT owns equity in AIDP, but subsidiary relationship does not exist. I like AIDP. They can make a 3d photo from CT, MRI or PET scan or other data source, and I foresee other possible uses than in the heart business.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext